Intended for healthcare professionals

  1. Research
  2. Herd immunity from...
  3. Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis
Papers

Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis

BMJ 2003; 326 doi: https://doi.org/10.1136/bmj.326.7385.365 (Published 15 February 2003) Cite this as: BMJ 2003;326:365

Related articles

See more

Cited by...

  • Changes to the UK childhood immunisation schedule
  • Protection against Neisseria meningitidis nasopharyngeal colonization relies on antibody opsonization and phagocytosis by neutrophils
  • Genetic Diversity of Meningococcal Serogroup B Vaccine Antigens among Carriage Isolates Collected from Students at Three Universities in the United States, 2015-2016
  • Effect of Vaccine-Elicited Antibodies on Colonization of Neisseria meningitidis Serogroup B and C Strains in a Human Bronchial Epithelial Cell Culture Model
  • Kinetics of Meningococcal Serogroup C-Specific Functional Antibody Levels Up to 15 Years after a Single Immunization with a Meningococcal Serogroup C Conjugate Vaccine during Adolescence
  • Potential long term vaccine benefits poorly translate in cost effectiveness modelling
  • Evaluation of swabbing methods for estimating the prevalence of bacterial carriage in the upper respiratory tract: a cross sectional study
  • Kinetics of the long-term antibody response after meningococcal C vaccination in patients with juvenile idiopathic arthritis: a retrospective cohort study
  • Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X
  • Long-term seroprotection after an adolescent booster meningococcal serogroup C vaccination
  • Neisseria infection of rhesus macaques as a model to study colonization, transmission, persistence, and horizontal gene transfer
  • Prospects for eradication of meningococcal disease
  • Prevalence of Serum Bactericidal Antibody to Serogroup C Neisseria meningitidis in England a Decade after Vaccine Introduction
  • Effect of Increased CRM197 Carrier Protein Dose on Meningococcal C Bactericidal Antibody Response
  • Single Nucleotide Polymorphisms in the Toll-Like Receptor 3 and CD44 Genes Are Associated with Persistence of Vaccine-Induced Immunity to the Serogroup C Meningococcal Conjugate Vaccine
  • Baseline Meningococcal Carriage in Burkina Faso before the Introduction of a Meningococcal Serogroup A Conjugate Vaccine
  • Serum Antibody Kinetics following Nasal or Parenteral Challenge with Meningococcal Polysaccharide in Healthy Adults
  • Updated Postlicensure Surveillance of the Meningococcal C Conjugate Vaccine in England and Wales: Effectiveness, Validation of Serological Correlates of Protection, and Modeling Predictions of the Duration of Herd Immunity
  • Seroprevalence of Antibodies against Serogroup C Meningococci in England in the Postvaccination Era
  • Meningococcal C booster not recommended by evidence
  • Seroprotection against serogroup C meningococcal disease
  • The Magnitude of the Antibody and Memory B Cell Responses during Priming with a Protein-Polysaccharide Conjugate Vaccine in Human Infants Is Associated with the Persistence of Antibody and the Intensity of Booster Response
  • Meningococcal A, C, Y and W-135 polysaccharide-protein conjugate vaccines
  • Protective Meningococcal Capsular Polysaccharide Epitopes and the Role of O Acetylation
  • Early Appearance of Bactericidal Antibodies after Polysaccharide Challenge of Toddlers Primed with a Group C Meningococcal Conjugate Vaccine: What Is Its Role in the Maintenance of Protection?
  • Comparison and Correlation of Neisseria meningitidis Serogroup B Immunologic Assay Results and Human Antibody Responses following Three Doses of the Norwegian Meningococcal Outer Membrane Vesicle Vaccine MenBvac
Back to top